FSMLFRANKLIN SMALL CAP ENHANCED ETF
Seeks long-term capital appreciation via small-cap equity securities.
By Franklin Templeton Investments · Launched 2025
Annual Cost
0.45%
#2,233 of 5,854 · average
Fund Size
$117M
#2,840 of 5,854 · mid-size
Return (1Y)Goal
N/A
Track Record
8 months
#4,959 of 5,854 · young
Performance
Total-return NAV · USDGrowth of $10,000
$11,777+17.8%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundWhat it actually holds
By weightConcentration
Top 10 holdings = 15.4% of fund✓ well diversified
Bloom Energy Corporation
2.2%
Guardant Health Inc
1.6%
GULFPORT ENERGY CORP
1.5%
Box Inc.
1.5%
Axsome Therapeutics Inc.
1.5%
NLIGHT INC
1.5%
Bridgebio Pharma Inc
1.4%
IES Holdings Inc.
1.4%
Formfactor Inc
1.4%
KULICKE AND SOFFA INDUSTRIES INC
1.4%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
N/A
Max drawdown
-10.8%Mild
Worst peak-to-trough loss
Sharpe (3Y)
Unavailable
Needs 3+ years of history
Sortino (3Y)
Not yet
Needs 3+ years of history
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks long-term capital appreciation via small-cap equity securities.
- Strategy
- Pursues a multi-style, quantitative investment approach by investing primarily in equity securities of small capitalization companies. Utilizes a proprietary multi-factor scoring model focusing on quality, value, sentiment, and alternative factors, with a portfolio predominantly in U.S. companies.
- Inception date
- December 9, 2025
- Fund family
- Franklin Templeton Investments
Similar funds
Same asset class, closest by strategy & exposureWhat's next?
You've looked at FSML. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.
Data updated on 2026-08-04